Meperidine Hydrochloride Injection shortage
Current 6 presentations · 2 manufacturers · first FDA posting 2025-05-30 · last update 2026-10-14
Manufacturers: Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 05/30/2025 Updated 10/14/2026 |
| Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 05/30/2025 Updated 10/14/2026 |
| Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 05/30/2025 Updated 10/14/2026 |
| Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 05/30/2025 Updated 10/08/2026 | |
| Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 05/30/2025 Updated 10/08/2026 | |
| Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 05/30/2025 Updated 10/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)